Therapeutic Advances in Myelodysplastic Syndromes: From Investigation to Clinical Practice

Gain expert insights on current and emerging treatment options for managing low- intermediate- and high-risk myelodysplastic syndrome with a downloadable slideset from a satellite symposium an on-demand webcast and an expert commentary.

Share

Program Content

Activities

MDS Risk Stratification
Myelodysplastic Syndromes: Diagnosis and Risk Stratification
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Lower-risk MDS Strategies
Strategies for Managing Very Low–Risk, Low-Risk, and Intermediate-Risk MDS
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Higher-risk MDS Therapy
Latest Guidance on the Treatment of Higher-Risk MDS and Managing Relapsed/Refractory MDS
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

MDS Future Directions
Myelodysplastic Syndromes: Future Directions
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

No activities added yet

Activities

FAQs: Managing MDS
Managing Low- and High-Risk Myelodysplastic Syndromes: Experts Address FAQs
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 09, 2022

Expires: August 08, 2023

Faculty

cover img faculity

Amy E. DeZern, MD, MHS

Associate Professor
Oncology and Medicine
The Johns Hopkins University School of Medicine
Baltimore, Maryland

cover img faculity

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

cover img faculity

Amer Zeidan, MBBS, MHS

Associate Professor of Medicine (Hematology)
Chief, Division of Hematologic Malignancies
Yale Comprehensive Cancer Center and Smilow Cancer Hospital
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Bristol Myers Squibb

Karyopharm Therapeutics Inc.